NYSEARCA:XBI

SPDR S&P Biotech ETF Stock Forecast, Price & News

$77.06

+0.83 (+1.09%)

(As of 06/24/2022 04:00 PM ET)

Add

Today's Range: $74.29
▼
$77.65
50-Day Range: $62.81
▼
$87.77
52-Week Range: $61.78
▼
$141.50

Volume: 18.56 million shs
Average Volume: 14.58 million shs
Market Capitalization: $5.97 billion

P/E Ratio: N/A
Dividend Yield: 0.00%
Price Target: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive XBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer SSgA

Fund NameSPDR S&P Biotech ETF

Tax ClassificationRegulated Investment Company

SymbolNYSEARCA:XBI

Inception Date1/31/2006

Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio

Webwww.spdrs.com

Phone+1-866-7872257

Fund Focus

Asset ClassEquity

BenchmarkS&P Biotech Index

CategorySector

FocusHealth Care

Development LevelDeveloped Markets

RegionNorth America

Fund Statistics

Assets Under Management$7.17 billion

Average Daily Volume$13.70 million

Discount/Premium-0.10%

ETF Expenses

Management Fee0.35%

Other Expenses0.00%

Total Expenses0.35%

Fee Waiver0.00%

Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSgA Funds Management, Inc.

AdvisorSSgA Funds Management, Inc.

CustodianState Street Bank and Trust Company

DistributorState Street Global Advisors Funds Distributors, LLC

Transfer AgentState Street Bank and Trust Company

Trustee

Lead Market MakerVirtu Financial

Geographic Exposure of XBI

Currency Exposure of XBI

Sector Exposure of XBI

Industry Exposure of XBI

SPDR S&P Biotech ETF Frequently Asked Questions

How has SPDR S&P Biotech ETF's stock performed in 2022?: SPDR S&P Biotech ETF's stock was trading at $111.96 on January 1st, 2022. Since then, XBI shares have decreased by 31.2% and is now trading at $77.06.
View the best growth stocks for 2022 here.
Who are SPDR S&P Biotech ETF's key executives?: SPDR S&P Biotech ETF's management team includes the following people:
James E. Ross, President, Trustee (Age 52)
Peter A. Ambrosini, Chief Compliance Officer (Age 69)
Michael P. Riley, Vice President (Age 44)
Gary L. French, Treasurer (Age 64)
John W. Clark, Assistant Treasurer (Age 46)
Matthew W. Flaherty, Assistant Treasurer (Age 42)
Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)
Mary Moran Zeven, Secretary (Age 52)
Scott M. Zoltowski, Assistant Secretary (Age 44)
Dave Kelly, Independent Trustee
What other stocks do shareholders of SPDR S&P Biotech ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Biotechnology ETF (IBB), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).
What is SPDR S&P Biotech ETF's stock symbol?: SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

Who are SPDR S&P Biotech ETF's major shareholders?: SPDR S&P Biotech ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Goldman Sachs Group Inc. (0.00%), Jane Street Group LLC (0.00%), Matrix Capital Management Company LP (2.52%), Clal Insurance Enterprises Holdings Ltd (2.64%), Twin Tree Management LP (0.00%) and Healthcare of Ontario Pension Plan Trust Fund (1.00%).
Which institutional investors are selling SPDR S&P Biotech ETF stock?: XBI stock was sold by a variety of institutional investors in the last quarter, including Healthcare of Ontario Pension Plan Trust Fund, Goldman Sachs Group Inc., BlackRock Inc., Bank of Nova Scotia, UBS Group AG, Bank of America Corp DE, Cutler Group LP, and HAP Trading LLC.
Which institutional investors are buying SPDR S&P Biotech ETF stock?: XBI stock was purchased by a variety of institutional investors in the last quarter, including Matrix Capital Management Company LP, Clal Insurance Enterprises Holdings Ltd, Twin Tree Management LP, Northwestern Mutual Wealth Management Co., Jane Street Group LLC, Q Global Advisors LLC, Blackstone Inc., and Main Management ETF Advisors LLC.
How do I buy shares of SPDR S&P Biotech ETF?: Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is SPDR S&P Biotech ETF's stock price today?: One share of XBI stock can currently be purchased for approximately $77.06.
How much money does SPDR S&P Biotech ETF make?: SPDR S&P Biotech ETF (NYSEARCA:XBI) has a market capitalization of $5.97 billion.
How can I contact SPDR S&P Biotech ETF?: SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The official website for SPDR S&P Biotech ETF is www.spdrs.com. The exchange traded fund can be reached via phone at +1-866-7872257.

This page (NYSEARCA:XBI) was last updated on 6/24/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources